Prebiotics in the management of pediatric gastrointestinal disorders: Position paper of the ESPGHAN special interest group on gut microbiota and modifications

J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):728-742. doi: 10.1002/jpn3.12134. Epub 2024 Jan 25.

Abstract

Prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit. Compared to probiotics there are few studies with prebiotics in children. Most studies have been performed using infant formula supplemented with prebiotics, while add-on prebiotic supplementation as prevention or treatment of childhood gastrointestinal disorders has rarely been reported. The aim of this position paper was to summarize evidence and make recommendations for prebiotic supplementation in children with gastrointestinal diseases. Recommendations made are based on publications up to January 1, 2023. Within the scope of the European Society for Paediatric Gastroenterology Hepatology and Nutrition Special Interest Group on Gut Microbiota and Modifications, as in our previous biotic recommendations, at least two randomized controlled clinical trials were required for recommendation. There are some studies showing benefits of prebiotics on selected outcomes; however, we cannot give any positive recommendations for supplementing prebiotics in children with gastrointestinal disorders.

Keywords: children; gastrointestinal disease; infant; oligosaccharides.

MeSH terms

  • Child
  • Gastrointestinal Diseases* / therapy
  • Gastrointestinal Microbiome*
  • Humans
  • Oligosaccharides
  • Prebiotics
  • Probiotics* / therapeutic use
  • Public Opinion

Substances

  • Oligosaccharides
  • Prebiotics

Grants and funding